"Regulatory Compliance for the Personal Care Industry" at the U.S. Food & Drug Administration in conjunction with The Center for Professional Advancement
This event has already occurred.
Related Insights
Federal Circuit Interprets IPR Estoppel Under 35 U.S.C. § 315(e)(2) to Permit at Trial Invalidity Theories Based on Prior Use or Sale